Groupe Inovie (PRIVATE.INOVIE)

Overall impact
B (74)

Commentary

Groupe Inovie is a strong overall performer. With a 'B' rating of 73.9 for overall impact (87th percentile compared to all companies), Groupe Inovie ranks 13th out of 76 industry peers, behind IMAC, Avedro, AnPac Bio-Medical Science and 9 others, and ahead of Enzo Biochem, Invitae, Check-Cap and 60 others. On top material causes for Groupe Inovie's industry (Healthcare Software & Services), Groupe Inovie performs well in Child and Maternal Health (95.8 score), Child and Maternal Health (88.1), Access to Affordable Healthcare (95.9) and 2 other causes where it received an 'A' score and performs poorly in Quality Lifelong Education (38.6 score).
Impact
Cause PRIVATE.INOVIE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2010
Employees
5,000
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Biotechnology & Pharmaceuticals
Share classes
PRIVATE.INOVIE
Description
INOVIE GROUP specializes in medical and health diagnostics services.
Material causes
Ethos considers the following causes material for Groupe Inovie, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.